Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.
about
Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageChronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BNon-invasive diagnosis of liver fibrosis and cirrhosis.Non-invasive diagnosis of liver fibrosis in chronic hepatitis CAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis.Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.The 2013 symposium on pathology data integration and clinical decision support and the current state of field.CUFA algorithm: assessment of liver fibrosis using routine laboratory data.Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis.Factors associated with the platelet count in patients with chronic hepatitis C.Platelet Counts and Genetic Polymorphisms of Alcohol Dehydrogenase-1B and Aldehyde Dehydrogenase-2 in Japanese Alcoholic Men.Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma.The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis.A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationA public health approach to hepatitis C control in low- and middle-income countries.Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver BiopsyDiagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 YearsAwareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer.Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience.Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India.Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysisThe de ritis ratio: the test of time.Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis.Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients.Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.
P2860
Q24188065-7AB24F77-1399-4D3E-86B7-C2F680AC2716Q26773289-438222E6-E816-4221-9FB7-4134ADB741C3Q26773585-57A8D87E-E442-4A93-A675-8A8BA8FD7E5AQ26777511-0EABE442-FE2F-4D17-9657-6C69E6180F3AQ26777916-DAD57959-D5F7-4A93-AA1A-02C560EF0CC7Q26778033-83004BB2-DDF9-441E-9F42-C3635D9F8D3BQ26865956-FB25EB39-E631-4967-879B-6F9DF6694ADCQ30250088-43965103-5785-4EEB-9323-DC5C3FA489C0Q30358189-8C4EB45A-A31A-4199-938D-E274F38B35D4Q30374820-75E684FD-3E0F-441A-BFA4-A14C65DBA7F9Q30422586-C063D658-02AC-4A0B-8EE3-412868E5B5E4Q30786602-2FA1593A-016B-4CE3-85BB-D7B7719BACCFQ30834803-C9F449FA-3FF3-4AB4-A5D1-74D53BC2C873Q30853941-2C18993D-FDE1-44A9-904E-AE94A8BF9787Q33420784-90E1E704-F374-44EF-B602-5F204CCB03A6Q33437735-7F68FBEA-A197-4117-A4FB-A487F2879163Q33796032-29A0A849-7E8D-43E9-9A54-DFDFDC230A68Q33837518-D38A15B3-A9BD-4317-822F-D52D4BCD1DBFQ34072173-B9F3039B-E1BB-49B4-832D-D11824AFE5B4Q34105030-ADD86F2D-9BB8-4E3A-8C5B-6086F48BA47AQ35107005-D6602E9E-11A3-417B-8C04-D6CD1D71CFFBQ35164735-62818CF6-613A-40F2-886C-F28B6A81E936Q35168268-29BC9C9C-7EBD-434F-9D07-683ECF8E7579Q35785198-136CB67A-2FF3-4E16-969D-A29151294D25Q35791614-4E7E313B-8628-47B4-8296-611E4DB366D2Q36226755-1DB695A0-F231-453B-8B36-69CDE01FFD0EQ36406176-522871C1-329B-4F99-B799-7CB88D025DC3Q36547364-E2523DEE-18C2-4597-B6D8-E71287203EFFQ36727043-4803F717-54B3-40AB-9589-C8AB2DB5B2DCQ37305630-39D56399-62E7-4B7F-8B41-96B1A2E52AE5Q37350196-77373503-60F1-455F-B68C-BF395BBF6CE2Q37400943-1AB7A4E7-F8EB-4C2F-B933-CFE8E36FD745Q37420413-10B77B91-FBB9-43EE-87AB-23F3793EE4ABQ37455611-052ACB0A-53BA-4D9F-9392-A3973B484EBDQ37726058-CD84E129-AC18-479F-851E-0733D0F2AD61Q38213277-427FF0D9-E677-4871-8DCE-31C47E54C882Q39380465-E3659A6F-01CE-4FED-B161-D3676ADC3336Q39690146-DB6421D0-A7AA-4839-B725-EC4E2AD3CA83Q39821108-AACBDEC1-0DD4-4ABA-917F-1CC2726222A1Q40061048-0844FA7E-3B1F-4AF9-9F53-8930ECD20D1F
P2860
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Blood tests to diagnose fibros ...... nfection: a systematic review.
@ast
Blood tests to diagnose fibros ...... nfection: a systematic review.
@en
Blood tests to diagnose fibros ...... nfection: a systematic review.
@nl
type
label
Blood tests to diagnose fibros ...... nfection: a systematic review.
@ast
Blood tests to diagnose fibros ...... nfection: a systematic review.
@en
Blood tests to diagnose fibros ...... nfection: a systematic review.
@nl
prefLabel
Blood tests to diagnose fibros ...... nfection: a systematic review.
@ast
Blood tests to diagnose fibros ...... nfection: a systematic review.
@en
Blood tests to diagnose fibros ...... nfection: a systematic review.
@nl
P1476
Blood tests to diagnose fibros ...... nfection: a systematic review.
@en
P2093
Ngoc Wasson
Roger Chou
P304
P356
10.7326/0003-4819-158-11-201306040-00005
P407
P577
2013-06-01T00:00:00Z